CClinicalTrials.gg
Status unknownNCT04700605Updated Jan 8, 2021

Intra-rater Reliability and Agreement Between Two Dual Task Tests; WBB and Gait Test.

An observational study in Balance; Distorted, sponsored by Aalborg University Hospital. Status unknown at 1 site in Denmark. Open to participants aged 65 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2021-01-08.

Sponsored by Aalborg University Hospital · Observational

The sponsor has not verified this record recently (last verified Jan 2021), so the status shown — last known as Recruiting — may be out of date.
Study type
Observational
Model
Other
Time perspective
Cross-sectional
Enrollment
30
Ages
65 Years and older
Sex
All
01

Study summary

Agreement and intra-rater reliability between static balance test using Nintendo Wii Balance Board and gait test under dual-task conditions in community-dwelling older adults.

Read the detailed description

Participants:

Investigators aim to recruit a minimum of 30 participants aged 65 years or above through convenience sampling at an senior activity centre in the Municipality of Aalborg. Participants inclusion critiria is age about 65, the ability to stand for 30 seconds unaided and the ability to walk 8 meters. Exclusion critiria is severe cognitive impairment (e.g., dementia).

Procedure:

Each participant will undergo two testdays separated by approximately two weeks. Both testdays have the same number and order of tests and are placed approximately the same time of the day. At the first testday descriptive information for each participant is collected.

Measuring device:

The Nintendo Wii Balance Board (Nintendo, Kyoto, Japan) is a small portable force plate measuring sway ellipse area and sway speed.

Analysis:

Will include intra-rater reliability for each test and agreement between the two. Calculations of balance/gait costs will be made to unify the unit and to compare the two tests to each other. Results shown by intraclass correlation coeffients and Bland Altman plots.

02

Conditions studied

  • Balance; Distorted
03

In context

Lead sponsor

Aalborg University Hospital is the lead sponsor of 195 studies on the registry; 39 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
65 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Minimum 65 year-old community dwelling citizens at activity centers.

Inclusion criteria

  • Minimum 65 years old.
  • Community dwelling

Exclusion criteria

Exclusion Criteria:

  • Unable to stand unsupported for 30 seconds
  • Unable to walk 8 meters unsupported
05

Study design

Observational model
Other
Time perspective
Cross-sectional
Enrollment
30 participants (estimated)
Target follow-up
2 Weeks
Patient registry
Yes

Interventions

  • BehavioralDual task balance test

    Participants will be conducting two dual task tests; an 8m gait test and a Wii Balance Board test with simultaneous various cognitive tests.

06

What researchers measure

Primary outcomes

  1. Intra-rater reliability for the gait test and the WBB test.

    Comparing the dual task costs for each test between test and retest. Assessments through intraclass correlation coefficient and reportings in accordance with Guidelines for Reporting Reliability and Agreement Studies (GRRAS).

    Time frame: Through study completion, app. 8 months.

Secondary outcomes

  1. Agreement between the gait test and the WBB test as dual task measurements.

    Comparing the dual task costs between the gait test and the Wii Balance Board test. Data assessment through Bland Altman plots and reportings in accordance with Guidelines for Reporting Reliability and Agreement Studies (GRRAS).

    Time frame: Through study completion, app. 8 months.

  2. Descriptive data.

    Qustionnairies consisting of Tilburg Frailty Indicator, Vulnerable Elders Survey 13, Short Falls Efficacy Scale, previous falls, medications and Orientations-Memory-Concentrations test. Data assessment through histograms and Shapiro Wilk tests and reported by means and standard deviations, medians and interquartile ranges, and numbers and percentages.

    Time frame: Through study completion, app. 8 months.

07

Study locations

1 of 1 sites recruiting
  • Liselund Aktivitets Center
    Vodskov, Aalborg 9310, Denmark
    Recruiting
08

References and documents

Study documents

  • Study protocol · Oct 27, 2020

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: Undecided

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 8, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04700605
Lead sponsor
Aalborg University Hospital
Responsible party
Martin Eriksen (Medical student, Aalborg University Hospital) — Principal investigator
First posted
Jan 8, 2021
Start date
Oct 27, 2020
Primary completion
Jan 6, 2021 (estimated)
Completion
Jan 6, 2021 (estimated)
Last update
Jan 8, 2021

Study contacts

Eriksen, student
Contact
martin.eriksen@rn.dk
004522234454
Gade, MD
Contact
gustav.soerensen@rn.dk
004552505753
Martin Eriksen
principal investigator · Aalborg University Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Jan 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion